SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-19-008816
Filing Date
2019-10-03
Accepted
2019-10-03 16:06:00
Documents
4
Period of Report
2019-09-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K f8-k.htm 8-K 45671
2 EX-10.1 ex-10d1.htm EX-10.1 26189
3 EX-10.2 ex-10d2.htm EX-10.2 27396
4 EX-10.3 ex-10d3.htm EX-10.3 29525
  Complete submission text file 0001558370-19-008816.txt   129999
Mailing Address P.O. BOX 130235 ANN ARBOR MI 48113
Business Address P.O. BOX 130235 ANN ARBOR MI 48113 734-245-1700
Gemphire Therapeutics Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 191135593
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences